BioGenex Laboratories
1981
FOUNDED
PUBLIC
STATUS
201-300
EMPLOYEES
BGNX
STOCK SYMBOL
Description
Bio-Genex Laboratories Inc is a United States based company engaged in the business of designing, developing and commercializing molecular pathology systems for cancer diagnosis, prognosis, precession medicine and life science research. Its products include Xmatrx systems, i6000 systems, i500 Plus, EZ-Retriever, IHC primary antibodies, microRNA probes, special stains, and IHC/ISH detection kits, among others. The product areas in which the company focuses on are multiple fully automated molecular pathology workstations, Immunohistochemistry, In-situ hybridization, Fluorescence in-situ hybridization, Multiplex stains, In-situ PCR, and MicroRNA and HPV probe system. The organization has a business presence all around the globe.
Primary Industry
Diagnostic Equipment
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
GREY
Primary Office
- 49026 Milmont Drive
- Fremont, CA 94538
- United States
+1 (510) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore BioGenex Laboratories’s full profile, request a free trial.
BioGenex Laboratories Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| 364.00 |
BioGenex Laboratories Financials Summary
|
In Thousands,
USD |
TTM
31-Dec-2010
|
FY 2010
31-Dec-2010
|
FY 2009
31-Dec-2009
|
FY 2008
31-Dec-2008
|
|---|---|---|---|---|
| Revenue | 14,364 | 14,364 | 16,850 | 15,553 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
BioGenex Laboratories Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore BioGenex Laboratories‘s full profile, request access.
Request full access to PitchBookBioGenex Laboratories Competitors (16)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Crescendo Bioscience | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 000000&0 | 00000 |
| 0000000000 | Venture Capital-Backed | Rehovot, Israel | 000.00 | 00000000000 | 000.00 | |
| 000000000 00000000 | Corporation | Malvern, PA | 0000 | |||
| 0000000 0000000000 | Corporation | Carlsbad, CA | 000 | 0000 | 000000000 | 0000 |
| 00000000 | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 00000000000 | 00000 |
BioGenex Laboratories Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Krishan Kalra Ph.D | Founder, Chairman & Chief Executive Officer | ||
| David Sheldon | Chief Financial Officer | ||
| George Su Ph.D | Director, Operations |
BioGenex Laboratories Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 0000000 00000 00.0 | BioGenex Laboratories | Founder, Chairman & Chief Executive Officer | 000 0000 |